Studies on LKB1 mutant mice have shown that LKB1 deletion in lungs leads to adenocarcinoma formation [27], LKB1 deletion in skeletal muscles leads to glucose uptake defects as well as growth and development defects [17], and liver-specific LKB1 deletion leads to metabolic defects [31]. Here, STK11 is linked to adenocarcinoma.